8th Jul 2016 10:56
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||||
a)
| Name
| Andrew Derodra
| ||||||
2
| Reason for the notification
| |||||||
a)
| Position/status
| PDMR
| ||||||
b)
| Initial notification /Amendment
| Initial Notification | ||||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||||
a)
| Name
| Vectura Group plc | ||||||
b)
| LEI
| |||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of 0.025 p
GB00B01D1K48
| ||||||
b)
| Nature of the transaction
| Exercise of share awards originally granted by Skyepharma PLC following merger with Vectura Group plc over 344,267 Vectura Ordinary Shares and sale of 263,364 of the Ordinary Shares acquired in Vectura
| ||||||
c)
| Price(s) and volume(s)
|
| ||||||
d)
| Aggregated information - Aggregated volume - Price - Total
|
263,364 £1.51822 £399,844.49
| ||||||
e)
| Date of the transaction
| 7 July 2016 | ||||||
f)
| Place of the transaction
| London Stock Exchange XLON | ||||||
Related Shares:
VEC.L